Active-ingredient Dossier
["ciprofloxacin Hydrochloride"
Active-ingredient Dossier for ["ciprofloxacin Hydrochloride" (fluoroquinolone antibiotic). Australian brands, products, PBS listings, PBAC outcomes —…
- Brand: AURIXIN
- Therapeutic area: Infectious Disease
What is
Ciprofloxacin Hydrochloride Ciprofloxacin Hydrochloride is a fluoroquinolone antibiotic.
Australian brands containing
Ciprofloxacin Hydrochloride The following brands containing ciprofloxacin hydrochloride are registered on the ARTG: — C-FLOX — CILOXAN — APO-CIPROFLOXACIN — CILOQUIN — CIPROFLOXACIN SANDOZ — CIPROFLOXACIN-WGR — CIPROL — IPC-CIPROFLOXACIN — APX-CIPROFLOXACIN — ARFLOX — AURO-CIPROFLOXACIN — CIFRAN
Therapeutic areas
Ciprofloxacin Hydrochloride is registered in Infectious Disease (13 brands) and Ophthalmology (2 brands).
Sponsor landscape
The ingredient is marketed by eight sponsors: Arrotex Pharmaceuticals, Novartis Pharmaceuticals, Strides Pharma Science, Alphapharm, Sun Pharma, and Sandoz.
PBS and regulatory activity
Two brands containing ciprofloxacin hydrochloride have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 July 2006, and no AusPAR has been issued for this ingredient.